Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Large trials confirm immunogenicity of H1N1 vaccines.

× No keyword cloud information.

6 in total

1. A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Authors: Karl-Heinz Herbinger; Frank von Sonnenburg; Hans Dieter Nothdurft; Pamela Perona; Astrid Borkowski; Elena Fragapane; Uwe Nicolay; Ralf Clemens
Journal: Hum Vaccin Immunother Date: 2013-09-20 Impact factor: 3.452

2. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Authors: R Bodewes; J H C M Kreijtz; M M Geelhoed-Mieras; G van Amerongen; R J Verburgh; S E van Trierum; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal: J Virol Date: 2011-01-12 Impact factor: 5.103

3. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

Authors: Claire S Waddington; W T Walker; C Oeser; A Reiner; T John; S Wilkins; M Casey; P E Eccleston; R J Allen; I Okike; S Ladhani; E Sheasby; K Hoschler; N Andrews; P Waight; A C Collinson; P T Heath; A Finn; S N Faust; M D Snape; E Miller; A J Pollard
Journal: BMJ Date: 2010-05-27

4. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.

Authors: Lamberto Manzoli; Corrado De Vito; Georgia Salanti; Maddalena D'Addario; Paolo Villari; John P A Ioannidis
Journal: PLoS One Date: 2011-09-06 Impact factor: 3.240

5. An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients.

Authors: Susanna Esposito; Elisa Meregalli; Cristina Daleno; Luciana Ghio; Claudia Tagliabue; Antonia Valzano; Domenico Serra; Carlotta Galeone; Alberto Edefonti; Nicola Principi
Journal: Nephrol Dial Transplant Date: 2010-10-25 Impact factor: 5.992

6. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

Authors: Heath A Kelly; Sheena G Sullivan; Kristina A Grant; James E Fielding
Journal: Influenza Other Respir Viruses Date: 2012-10-19 Impact factor: 4.380

6 in total